t 47d Search Results


t47d  (ATCC)
99
ATCC t47d
T47d, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/bio_rxiv__64898__2026__03__11__711115-176-64-78?v=ATCC
Average 99 stars, based on 1 article reviews
t47d - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
human breast cancer cell lines  (ATCC)
97
ATCC human breast cancer cell lines
Human Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pmc05705264-102-0-14?v=ATCC
Average 97 stars, based on 1 article reviews
human breast cancer cell lines - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
t47d  (DSMZ)
95
DSMZ t47d
T47d, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pm41803880-73-8-30?v=DSMZ
Average 95 stars, based on 1 article reviews
t47d - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
tamoxifen resistant t 47d tam1  (ATCC)
94
ATCC tamoxifen resistant t 47d tam1
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
Tamoxifen Resistant T 47d Tam1, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pmc13132456-34-12-19?v=ATCC
Average 94 stars, based on 1 article reviews
tamoxifen resistant t 47d tam1 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
collection human endocarditis hdp 98354 cdc 3437 70 human  (ATCC)
90
ATCC collection human endocarditis hdp 98354 cdc 3437 70 human
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
Collection Human Endocarditis Hdp 98354 Cdc 3437 70 Human, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pm12807180-75-288-301?v=ATCC
Average 90 stars, based on 1 article reviews
collection human endocarditis hdp 98354 cdc 3437 70 human - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
goat polyclonal anti claudin 1  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology goat polyclonal anti claudin 1
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
Goat Polyclonal Anti Claudin 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pmc07464080-90-7-12?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
goat polyclonal anti claudin 1 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
breast cancer cell line t-47d  (CEM Corporation)
90
CEM Corporation breast cancer cell line t-47d
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
Breast Cancer Cell Line T 47d, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/10__1080_slash_17518253__2022__2150394-70-6-13?v=CEM+Corporation
Average 90 stars, based on 1 article reviews
breast cancer cell line t-47d - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
evs isolated from t-47d to-nfat3  (NanoSight ltd)
90
NanoSight ltd evs isolated from t-47d to-nfat3
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
Evs Isolated From T 47d To Nfat3, supplied by NanoSight ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pmc07265394__41598_2020_65844_MOESM1_ESM-22-10-27?v=NanoSight+ltd
Average 90 stars, based on 1 article reviews
evs isolated from t-47d to-nfat3 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
t-47d  (Walser GmbH)
90
Walser GmbH t-47d
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
T 47d, supplied by Walser GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pmc04571436-7-1-12?v=Walser+GmbH
Average 90 stars, based on 1 article reviews
t-47d - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
t-47d breast cancer cell line–derived xenograft model  (WuXi AppTec)
90
WuXi AppTec t-47d breast cancer cell line–derived xenograft model
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
T 47d Breast Cancer Cell Line–Derived Xenograft Model, supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/10__1158_slash_1078___0432__ccr___17___0670-86-4-18?v=WuXi+AppTec
Average 90 stars, based on 1 article reviews
t-47d breast cancer cell line–derived xenograft model - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
ptripz-psmd2 shrna plasmid  (Broad Institute Inc)
90
Broad Institute Inc ptripz-psmd2 shrna plasmid
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
Ptripz Psmd2 Shrna Plasmid, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pmc08548400-334-37-51?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
ptripz-psmd2 shrna plasmid - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
cell lines t-47d  (ONTOP PHARMACEUTICALS LIMITED)
90
ONTOP PHARMACEUTICALS LIMITED cell lines t-47d
MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) <t>T-47D,</t> were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).
Cell Lines T 47d, supplied by ONTOP PHARMACEUTICALS LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t+47d/pm40342587-129-1-8?v=ONTOP+PHARMACEUTICALS+LIMITED
Average 90 stars, based on 1 article reviews
cell lines t-47d - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) T-47D, were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).

Journal: PLOS One

Article Title: Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells

doi: 10.1371/journal.pone.0348260

Figure Lengend Snippet: MTT assay measured cell viability of ER-positive breast cancer cells: (A) MCF-7 and (B) T-47D, were treated with (+E 2 ) or without (−E 2 ) 17β-estradiol at physiologic level (10 nM E 2 ) in the presence of nontoxic concentrations of IVM (1, 3, 5 μM) or 4-OHT (5, 10 μM) as a positive control for 5 days. (C–E) The inhibitory effect of IVM on ERα and HER2 protein levels of ER-positive breast cancer was performed after the treatments with various concentrations of IVM with (+E 2 ) or without (−E 2 ) 17β-estradiol (10 nM E 2 ) for 24 h in MCF-7. (F) mRNA expression of the ESR1 gene (ERα) was determined by qPCR analysis in MCF-7 cells. The graphs showed the mean ± SEM. The blue and red asterisks highlight the significant differences in comparison to non-treatment without (−E 2 ) and with (+E 2 ), respectively. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the non-treatment control (n = 3).

Article Snippet: The ER-positive breast cancer cell lines: MCF-7 and T-47D, along with the tamoxifen-resistant T-47D Tam1, were obtained from the American Type Culture Collection: ATCC (Virginia, USA).

Techniques: MTT Assay, Positive Control, Expressing, Comparison, Control